• Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 04 Jan 2025 02:16:14   America/Chicago


    Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 4, 2025 Share Link copied to clipboard. Shares of Viridian Therapeutics, Inc.
    Read more...
Share on,